Clinical Feedback

Teresa Rocha, Tissue Viability Clinical Nurse Specialist, The Royal Marsden Hospital NHS Foundation Trust: “We have been using heel up® for the past 3 months and successfully reduced acquired pressure damage to zero! It is not only how we managed to prevent pressure acquired damage but also how patients feel about the product. Our patient cohorts are very complex, as they’ve either undergone a lengthy procedure (>15hours surgery) with consequent prolonged stay in critical care, palliative and end-of-life units often presenting lymphorrhea. We also see paediatric and young adults, among others, all requiring a high level of care, prevention and management. The Heel Up® has put together in one product, all characteristics we were hoping: patient comfort, absorbent material (avoiding moisture acquired damage) and controlling damage acquired on lymphoedema patients, easy to use, single patient use – approved by Infection Control Team, can be used with Flowtron Therapy, extremely cost-effective, excellent customer service with company who kindly provided training and support to our hospitals. So far we’ve been very happy with the range and are not looking to change to another product any time soon.”


Allaina Eden, Physiotherapy Service Lead for Critical Care, Cardiothoracic Surgery and Cardiology, Papworth Hospital: “We have used a number of Heel Up® within ICU, with the physio and nursing staff all reporting positive feedback. They are easy to use, and our Tissue Viability team are much happier with the surface cover compared with other products. We’ve had no issues with skin integrity when using the Heel Up®. We have tended to use the medium and large sizes finding these the most appropriate for our patients.”


Delilah Rooney, Tissue Viability Specialist Nurse, University Hospitals Bristol: In August 2018, University Hospital Bristol undertook a trial of the Heel Up® offloading boot. We were looking for a cost-effective product that effectively offloaded heels in line with NICE guidance for those patients who are high risk or already have sustained ulceration. “The Heel Up® range was well received by the wards that we trialled it on. They are made of soft white material which patients commented was preferable to the non-disposable plastic alternatives. During the trial those patients who used the Heel Up® did not develop new pressure damage, and those who had damage present either improved or remained stable. The product was felt to be easy to use, and we were well supported with all our education/resource needs. Overall, we felt this was a clinically acceptable cost[1]effective solution, and we were happy to begin the process of adding it to the equipment we use in our trust.”